alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Editorial Note on Part 890
Editorial Note: Nomenclature changes to part 890 appear at 73 FR 35341, June 23, 2008.

§ 890.1925 Isokinetic testing and evaluation system. ( a ) *Identification.* An isokinetic testing and evaluation system is a rehabilitative exercise device intended for medical purposes, such as to measure, evaluate, and increase the strength of muscles and the range of motion of joints.
( b ) *Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 890.9.
[48 FR 53047, Nov. 23, 1983, as amended at 63 FR 59230, Nov. 3, 1998]
<PAGE>   1

                                                                   EXHIBIT 23.2


                CONSENT OF NETHERLAND, SEWELL & ASSOCIATES, INC.


To the Board of Directors of Forcenergy Inc:

We hereby consent to the incorporation by reference in the Registration
Statement on Form S-8 (File No. 33-80919) of Forcenergy Inc of our reports
dated March 5, 1999, March 4, 1998 and March 3, 1997, of the estimates of net
proved oil and natural gas reserves of Forcenergy Inc, and their present
values, as of January 1, 1999, 1998 and 1997, included in this Annual Report on
Form 10-K for the year ended December 31, 1998.



                                         NETHERLAND, SEWELL & ASSOCIATES, INC.



                                     By:     /s/DANNY D. SIMMONS
                                         --------------------------------------
                                         Danny D. Simmons
                                         Senior Vice President
                                         Houston, Texas
                                         June 9, 1999
EXHIBIT 5.1

             [LETTERHEAD OF SILVERMAN, CHERNIS, SHIN & BYRNE, P.C.]

                                                     October 23, 2001

Log On America, Inc.
One Cookson Place
6th Floor
Providence, RI 02903

              Re: Registration Statement on Form S-3

Gentlemen:

      We have acted as counsel to Log On America, Inc. (the "Company"), a
Delaware corporation, pursuant to Registration Statement on Form S-3, as filed
with the Securities and Exchange Commission on October 19, 2001 (the
"Registration Statement") covering (a) 1,666,667 shares of the Company's Common
Stock, par value $.001 per share (the "Common Stock") issuable upon conversion
of the Company's Series B Convertible Preferred Stock; (b) 300,000 shares of
Common Stock issuable upon exercise of the common stock purchase warrant dated
as of August 22, 2001; and (c) an aggregate of 1,036,604 shares of Common Stock
issued to Kenneth Cornell, Charles Cleary, Raymond Paolo, Silverman, Chernis,
Shin & Byrne, P.C. and Ganfer & Shore, LLP.

      In acting as counsel for the Company and arriving at the opinion as
expressed below, we have examined and relied upon originals or copies, certified
or otherwise identified to our satisfaction, of such records of the Company,
agreements and other instruments, certificates of officers and representatives
of the Company, certificates of public officials and other documents as we have
deemed necessary or appropriate as a basis for the opinions expressed herein.

      In connection with our examination we have assumed the genuineness of all
signatures, the authenticity of all documents tendered to us as originals, the
legal capacity of natural persons and the conformity to original documents of
all documents submitted to us as certified or photostated copies.

      Based on the foregoing, and subject to the qualifications and limitations
set forth herein, it is our opinion that:

      1. The Company has authority to issue the Common Stock in the manner and
under the terms set forth in the Registration Statement; and


<PAGE>

Log On America, Inc.
Page 2
October 23, 2001


      2. The Common Stock has been duly authorized and when issued, delivered
and paid for in accordance with their respective terms, will be validly issued,
fully paid and non-assessable.

      We express no opinion with respect to the laws other than those of the
State of New York and federal laws of the United States of America, and we
assume to responsibility as to the applicability thereto, or the effect thereon,
of the laws of any other jurisdiction.

      We hereby consent to the filing of this opinion as Exhibit 5.1 to the
Registration Statement and its use as part of the Registration Statement.

      We are furnishing this opinion to the Company solely for its benefit in
connection with the Registration Statement. It is not to be used, circulated,
quoter or otherwise referred to for any other purpose. Other than the Company,
no one is entitled to rely on this opinion.

                                          Very truly yours,

                                          SILVERMAN, CHERNIS, SHIN & BYRNE, P.C.
Editorial Note on Part 880
Editorial Note: Nomenclature changes to part 880 appear at 73 FR 35341, June 23, 2008.

§ 880.6760 Protective restraint. ( a ) *Identification.* A protective restraint is a device, including but not limited to a wristlet, anklet, vest, mitt, straight jacket, body/limb holder, or other type of strap, that is intended for medical purposes and that limits the patient's movements to the extent necessary for treatment, examination, or protection of the patient or others.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 880.9.
[61 FR 8439, Mar. 4, 1996, as amended at 66 FR 46952, Sept. 10, 2001; 84 FR 71815, Dec. 30, 2019]
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

DWAYNE MARSHALL,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

No. 4D17-1953

[August 31, 2017]

Appeal of order denying rule 3.800 motion from the Circuit Court for 

the Seventeenth Judicial Circuit, Broward County; Dennis D. Bailey, 

Judge; L.T. Case No. 15-1527CF10A.

Dwayne Marshall, Florida City, pro se.

No appearance required for appellee.

PER CURIAM.

Affirmed.

GERBER, C.J., DAMOORGIAN and LEVINE, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
Six months ended June 30,
                                                 1999            1998
                                            ------------     ------------
Net loss                                    $ 14,486,825     $(18,398,170)
Interest expense                                 958,115          379,711
Amortization of debt costs                       359,812          565,847
Income tax                                       114,060               --
                                            ------------     ------------

Profit (loss) before fixed charges            15,918,812      (17,452,612)

Fixed charges                                  1,431,987          945,558

Ratio of net profit (loss) before fixed
      charges to fixed charges                      11.1               N/A

Sufficiency of earnings to cover fixed
      charges                               $ 14,486,825     $         N/A
Exhibit 32.1


CERTIFICATION PURSUANT TO


18 U.S.C. SECTIONS 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report on Form 10-Q of Ebix, Inc. (the “Company”) for the period ended September 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robin Raina, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act of 2002, that:





1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


By:/s/ Robin RainaName: Robin RainaChief Executive Officer


May 10, 2011
Multiple files are bound together in this PDF Package.

Adobe recommends using Adobe Reader or Adobe Acrobat version 8 or later to work with 

documents contained within a PDF Package. By updating to the latest version, you’ll enjoy 

the following benefits: 

• Efficient, integrated PDF viewing 

• Easy printing 

• Quick searches 

Don’t have the latest version of Adobe Reader? 

Click here to download the latest version of Adobe Reader

If you already have Adobe Reader 8, 

click a file in this PDF Package to view it.
# C_2016335EN.01004601.xml

| 12.9.2016 | EN | Official Journal of the European Union | C 335/46 |
| --- | --- | --- | --- |

12.9.2016

EN

Official Journal of the European Union

C 335/46

---

Order of the General Court of 19 July 2016 — Italy v Commission

(Case T-770/14) (1)

1

((ERDF - Regulation (EC) No 1083/2006 - Italy-Malta Cross-border Cooperation Programme 2007-2013 - Failure to comply with the deadlines - Automatic decommitment - Proportionality - Principle of cooperation - Principle of partnership - Force majeure - Obligation to state reasons - Action manifestly lacking any foundation in law))

(2016/C 335/60)

Language of the case: Italian

Parties

Parties

Applicant: Italian Republic (represented by: G. Palmieri and P. Gentili, Agents)

Applicant:

Defendant: European Commission (represented by: B.-R. Killmann and D. Recchia, Agents)

Defendant:

Re:

Re:

Action based on Article 263 TFEU and seeking, first, annulment of Commission note Ares (2014) 2975571 of 11 September 2014, by which the Commission notified the Italian Republic of the automatic decommitment, on 31 December 2013, of a part of the resources relating to European Regional Development Fund (ERDF) commitments referred to in the Italy-Malta Cross-border Cooperation Programme 2007-2013, and, secondly, that the General Court declare the expenditure relating to the ImaGenX, Simit and PIM Energethica projects eligible for financing.

Operative part of the order

Operative part of the order

| 1. | The action is dismissed. |
| --- | --- |

1.

The action is dismissed.

| 2. | The Italian Republic is ordered to pay the costs. |
| --- | --- |

2.

The Italian Republic is ordered to pay the costs.

---

(1)  OJ C 26, 26.1.2015.

1

---
[if !vml]>[endif]>
[if !vml]>[endif]>
Youhave reached the Federal Depository Library Program Electronic Collection(FDLP/EC) Archive. This archive assures ongoing access to publications in theFDLP/EC. Access to publications in the archive is available through GPO's suiteof cataloging and locator services, including the Catalog of U.S. GovernmentPublications (CGP).
**Title:****Iowa�s forests
 
1999 | 2008 | 2013
 
SuDoc Number:A 13.80:F 76/IO 9/
Item Number:0083-B-05 (online)
CGP System Number:000869436
 
September 27, 2017
 
 
 **
§ 601.31 Definition. For purposes of this part,*diagnostic radiopharmaceutical* means: ( a ) An article that is intended for use in the diagnosis or monitoring of a disease or a manifestation of a disease in humans and that exhibits spontaneous disintegration of unstable nuclei with the emission of nuclear particles or photons; or
( b ) Any nonradioactive reagent kit or nuclide generator that is intended to be used in the preparation of such article as defined in paragraph (a) of this section.
Exhibit 32.1

Certification Pursuant to § 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. §
1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, in connection with the filing of the Form 10-Q of STERIS Corporation (the Company) for the quarter ended June 30, 2006, as filed with the Securities and
Exchange Commission on the date hereof (the Report), each of the undersigned officers of the Company certifies, that, to such officers knowledge:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the
periods expressed in the Report.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



/S/ LES C. VINNEYName:

Les C. VinneyTitle:

President and Chief Executive Officer (Principal Executive Officer)/S/ LAURIE BRLASName:

Laurie BrlasTitle:

Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)


Dated: August 8, 2006
# C_2016305EN.01003401.xml

| 22.8.2016 | EN | Official Journal of the European Union | C 305/34 |
| --- | --- | --- | --- |

22.8.2016

EN

Official Journal of the European Union

C 305/34

---

Order of the General Court of 10 June 2016 — Klymenko v Council

(Case T-494/14) (1)

1

((Action for annulment - Common foreign and security policy - Restrictive measures adopted in view of the situation in Ukraine - Freezing of funds - List of persons, entities and bodies covered by the freezing of funds and economic resources - Inclusion of the applicant’s name - Period allowed for commencing proceedings - Admissibility - Proof that inclusion on the list is justified - Manifestly well-founded action))

(2016/C 305/47)

Language of the case: English

Parties

Parties

Applicant: Oleksandr Klymenko (Kyiv, Ukraine) (represented by: M. Shaw QC, and I. Quirk, Barrister)

Applicant:

Defendant: Council of the European Union (represented by: A. Vitro and J.-P. Hix, Agents)

Defendant:

Re:

Re:

Application for annulment of Council Implementing Decision 2014/216/CFSP of 14 April 2014 implementing Decision 2014/119/CFSP concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Ukraine (OJ 2014 L 111, p. 91) and of Council Implementing Regulation (EU) No 381/2014 of 14 April 2014 implementing Regulation (EU) No 208/2014 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Ukraine (OJ 2014 L 111, p. 33), in so far as they relate to the applicant.

Operative part of the order

Operative part of the order

| 1. | Council Implementing Decision 2014/216/CFSP of 14 April 2014 implementing Decision 2014/119/CFSP concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Ukraine, and Council Implementing Regulation (EU) No 381/2014 of 14 April 2014 implementing Regulation (EU) No 208/2014 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Ukraine are annulled in so far as they relate to Mr Oleksandr Klymenko. |
| --- | --- |

1.

Council Implementing Decision 2014/216/CFSP of 14 April 2014 implementing Decision 2014/119/CFSP concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Ukraine, and Council Implementing Regulation (EU) No 381/2014 of 14 April 2014 implementing Regulation (EU) No 208/2014 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Ukraine are annulled in so far as they relate to Mr Oleksandr Klymenko.

| 2. | The Council of the European Union shall bear its own costs and pay those incurred by Mr Klymenko. |
| --- | --- |

2.

The Council of the European Union shall bear its own costs and pay those incurred by Mr Klymenko.

---

(1)  OJ C 292, 1.9.2014.

1

---
<TABLE> <S> <C>

<ARTICLE> 9
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FRONTIER
FINANCIAL CORPORATION AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
10-Q.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                          46,242
<INT-BEARING-DEPOSITS>                           5,150
<FED-FUNDS-SOLD>                                 7,620
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                    108,858
<INVESTMENTS-CARRYING>                          27,798
<INVESTMENTS-MARKET>                            28,516
<LOANS>                                        973,652
<ALLOWANCE>                                   (18,450)
<TOTAL-ASSETS>                               1,183,662
<DEPOSITS>                                     943,840
<SHORT-TERM>                                    39,708
<LIABILITIES-OTHER>                              8,993
<LONG-TERM>                                     55,202
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        91,224
<OTHER-SE>                                      44,695
<TOTAL-LIABILITIES-AND-EQUITY>               1,183,662
<INTEREST-LOAN>                                 44,317
<INTEREST-INVEST>                                5,180
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                                49,497
<INTEREST-DEPOSIT>                              17,151
<INTEREST-EXPENSE>                               2,336
<INTEREST-INCOME-NET>                           30,010
<LOAN-LOSSES>                                    (500)
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                 13,181
<INCOME-PRETAX>                                 18,916
<INCOME-PRE-EXTRAORDINARY>                      12,368
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    12,368
<EPS-BASIC>                                       0.71
<EPS-DILUTED>                                     0.70
<YIELD-ACTUAL>                                    5.36
<LOANS-NON>                                      4,535
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                18,098
<CHARGE-OFFS>                                    (244)
<RECOVERIES>                                        96
<ALLOWANCE-CLOSE>                               18,450
<ALLOWANCE-DOMESTIC>                            18,450
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0


</TABLE>
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<PERIOD  TYPE>     3-MOS
<FISCAL-YEAR-END>              MAR-31-2000
<PERIOD-END>                 SEPT  30-2000
<CASH>                             123,000
<SECURITIES>                             0
<RECEIVABLES>                    5,283,000
<ALLOWANCES>                     (581,000)
<INVENTORY>                      2,982,000
<CURRENT-ASSETS>                 8,031,000
<PP&E>                           6,578,000
<DEPRECIATION>                 (1,095,000)
<TOTAL-ASSETS>                  17,083,000
<CURRENT-LIABILITIES>            9,437,000
<BONDS>                                  0
<PREFERRED-MANDATORY>                    0
<PREFERRED>                              0
<COMMON>                        22,488,000
<OTHER-SE>                         805,000
<TOTAL-LIABILITY-AND-EQUITY>    17,083,000
<SALES>                          5,887,000
<TOTAL-REVENUES>                 5,887,000
<CGS>                            3,871,000
<TOTAL-COSTS>                    3,871,000
<OTHER-EXPENSES>               (1,491,000)
<LOSS-PROVISION>                         0
<INTEREST-EXPENSE>               (369,000)
<INCOME-PRETAX>                    429,000
<INCOME-TAX>                             0
<INCOME-CONTINUING>                397,000
<DISCONTINUED>                      32,000
<EXTRAORDINARY>                          0
<CHANGES>                                0
<NET-INCOME>                       429,000
<EPS-BASIC>                         0.04
<EPS-DILUTED>                         0.03


</TABLE>
**Exhibit32**

## **CERTIFICATION**

**The undersigned certify pursuant to18 U.S.C. § 1350, that:**

(1)                                The accompanying Quarterly Report on Form10-QSB for the period ended January 31, 2007 fully complies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and

(2)                                The information contained in the accompanying Reportfairly presents, in all material respects,the financial condition and results of operations of the Company.
| Date:  | March 12, 2007 |                                  |   | /s/ Rodney A. Young |   |
|--------|----------------|---------------------------------------|--------|---------------------|--------|
|   |           | Rodney A. Young                       |
|   |           | President and Chief Executive Officer |
|   |           |                                  |
|   |           |                                  |
| Date:  | March 12, 2007 |                                  |   | /s/ Dale H. Johnson |   |
|   |           | Dale H. Johnson                       |
|   |           | Chief Financial Officer               |

 

1

----
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.1280 Steerable catheter. ( a ) *Identification.* A steerable catheter is a catheter used for diagnostic and monitoring purposes whose movements are directed by a steering control unit.
( b ) *Classification.* Class II (performance standards).
Editorial Note on Part 874
Editorial Note: Nomenclature changes to part 874 appear at 73 FR 35341, June 23, 2008.

§ 874.1800 Air or water caloric stimulator. ( a ) *Identification.* An air or water caloric stimulator is a device that delivers a stream of air or water to the ear canal at controlled rates of flow and temperature and that is intended for vestibular function testing of a patient's body balance system. The vestibular stimulation of the semicircular canals produce involuntary eye movements that are measured and recorded by a nystagmograph.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 874.9.
[55 FR 48440, Nov. 20, 1990, as amended at 65 FR 2316, Jan. 14, 2000]
[if !vml]>[endif]>

[if !vml]>[endif]>

You have reached the FederalDepository Library Program Electronic Collection (FDLP/EC) Archive. Thisarchive assures ongoing access to publications in the FDLP/EC. Access to publicationsin the archive is available through GPO's suite of cataloging and locatorservices, including the Catalog of U.S. Government Publications (CGP). Archived copies of publications are retrieved in the event that publicationsare no longer available from the original publishing agency site. 
**Title:****Water-level data for theAlbuquerque Basin, New Mexico, October 1, 1986, through September 30, ...**
 
1986-1990
1995 | 1997 | 1998 | 1999
2000 | 2001 | 2002 | 2004 | 2006 | 2007 | 2008 | 2009
2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2017| 2018
 
SuDoc Number:I 19.76/15:
Item Number:0624-H-17 (online)
CGP systemNumber:000926687
 
June 27, 2019